↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$11.9MSold on the market
1Companies
Sep 24, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202616:10 | Sep 22, 2026 | RPRXRoyalty Pharma plc | EVP & Chairman, Partnering | S · Sell10b5-1 | $58.53 | −100,000 | 270,401 | -27% | −$5.9M | ||
| Aug 19, 202616:20 | Aug 18, 2026 | RPRXRoyalty Pharma plc | EVP & Chairman, Partnering | S · Sell10b5-1 | $59.97 | −100,000 | 370,401 | -21% | −$6.0M | ||
| Aug 19, 202616:20 | Aug 19, 2026 | RPRXRoyalty Pharma plc | EVP & Chairman, Partnering | G · Gift10b5-1 | — | −16,800 | 23,200 | -42% | — | ||
| Aug 7, 202617:12 | Aug 5, 2026 | RPRXRoyalty Pharma plc | EVP & Chairman, Partnering | A · Grant | — | +11,002 | 470,401 | +2% | — |